Coffelt, S. B. and de Visser, K. E. (2016) Revving up dendritic cells while braking PD-L1 to jump-start the cancer-immunity cycle motor. Immunity, 44(4), pp. 722-724. (doi: 10.1016/j.immuni.2016.03.014) (PMID:27096314)
|
Text
123492.pdf - Accepted Version 141kB |
Abstract
Although it is successful for some, most melanoma patients are refractory to T cell checkpoint inhibition. In this issue of Immunity, Merad and colleagues (2016) describe a dendritic-cell-based strategy to heighten the efficacy of therapeutic anti-PD-L1 and BRAF inhibitors in mouse melanoma models.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Coffelt, Professor Seth |
| Authors: | Coffelt, S. B., and de Visser, K. E. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
| Journal Name: | Immunity |
| Publisher: | Elsevier (Cell Press) |
| ISSN: | 1074-7613 |
| ISSN (Online): | 1097-4180 |
| Published Online: | 19 April 2016 |
| Copyright Holders: | Copyright © 2016 Elsevier |
| First Published: | First published in Immunity 44(4):722-724 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details